Keywords
How to Cite
Abstract
Background
Drug Information Centers form essential components in modern healthcare systems and provide appropriate, impartial, and evidence-based drug information to support rational prescribing, clinical decision-making, and patient safety. First established in the 1960s, such centers have evolved over time into multidisciplinary services encompassing a wide range of activities related to medication management.
Objective
This review describes the development, roles, and clinical impact of DICs globally and outlines challenges and future opportunities regarding enhancing their contributions to medicine safety.
Methodology
A global literature synthesis was conducted through such studies as those conducted in South Asia, the Middle East, Europe, and the United States. Particular emphasis was placed on assessing DIC-led interventions, technological advancements, and systemic barriers affecting their performance in low- and middle-income countries.
Results
Evidence from various healthcare settings suggests that some major DIC-related initiatives, such as structured drug query response, ADR reporting, antimicrobial stewardship activities, and formulary support, have significantly reduced medication errors and inappropriate antimicrobial prescribing while optimizing cost-effective therapy. Emerging technologies, such as electronic health record integration, telepharmacy platforms, AI applications, and pharmacogenomics, are reengineering the future of DIC operation toward more proactive, personalized, and data-driven models. However, substantial barriers to the effective delivery of clinical pharmacy services persist in LMICs, including insufficient funding, a shortage of trained personnel, weak digital infrastructure, and fragmented regulatory oversight.
Conclusion
This will require strengthening the DICs through sustainable financing, digital modernization, workforce development, and interprofessional collaboration to realize their full potential for contribution to rational drug use and patient safety. Well-resourced and technologically integrated DICs can be the hub for safe, effective, and equitable medication management in resilient health systems.